Eagle Pharmaceuticals, Inc.
EGRXDelisted Nov 26, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000827871
Eagle Pharmaceuticals, Inc. was delisted on Nov 26, 2024; its insiders filed their last Form 4 on Mar 1, 2024; 65 institutions reported holding it in 13F filings for Q3 2024, worth $31.9M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Eagle Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EGRX is no longer listed, so this page shows Q3 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 65
- −9 vs. Q2 2024
- Shares held
- 8.56M
- −1.01M (−10.6%) vs. Q2 2024
- Total value
- $31.9M
- −$21.6M (−40.4%) vs. Q2 2024
- New holders
- 12
- 11 more added
- Sold out
- 21
- 27 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 2 | $8.28K |
| Q1 2026 | 2 | $4.21K |
| Q4 2025 | 2 | $8.64K |
| Q3 2025 | 2 | $33.3K |
| Q2 2025 | 2 | $35.8K |
| Q1 2025 | 2 | $12.1K |
| Q4 2024 | 9 | $38.8K |
| Q3 2024 | 65 | $31.9M |
| Q2 2024 | 75 | $55.5M |
| Q1 2024 | 91 | $54.8M |
| Q4 2023 | 104 | $52.4M |
| Q3 2023 | 108 | $162.9M |
| Q2 2023 | 126 | $209.5M |
| Q1 2023 | 153 | $334.2M |
| Q4 2022 | 152 | $337.9M |
| Q3 2022 | 154 | $303.7M |
| Q2 2022 | 164 | $515.8M |
| Q1 2022 | 160 | $555.1M |
| Q4 2021 | 162 | $573.2M |
| Q3 2021 | 151 | $659.5M |
| Q2 2021 | 146 | $516.0M |
| Q1 2021 | 155 | $508.4M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Eagle Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 2,356,536 | $8.79M | 0.74% | +394,466+20.1% | Added |
| AIGH Capital Management LLC | 1,211,509 | $4.52M | 2.12% | 00.0% | Unchanged |
| Citigroup Inc | 1,000,389 | $3.73M | 0.00% | −1,166−0.1% | Reduced |
| Vanguard Group Inc | 579,507 | $2.16M | 0.00% | +15,111+2.7% | Added |
| AQR Capital Management LLC | 374,992 | $1.40M | 0.00% | −321,805−46.2% | Reduced |
| BlackRock, Inc. | 268,169 | $1.00M | 0.00% | +268,169 | New |
| Renaissance Technologies LLC | 256,350 | $956.2K | 0.00% | +12,100+5.0% | Added |
| Marshall Wace, LLP | 223,353 | $833.1K | 0.00% | +27,878+14.3% | Added |
| Morgan Stanley | 192,213 | $717.0K | 0.00% | −108,235−36.0% | Reduced |
| Two Sigma Advisers, LP | 185,058 | $690.3K | 0.00% | −39,759−17.7% | Reduced |
| Assenagon Asset Management S.A. | 183,592 | $684.8K | 0.00% | −1,745−0.9% | Reduced |
| J. Goldman & Co LP | 150,611 | $561.8K | 0.02% | −40,500−21.2% | Reduced |
| RBF Capital, LLC | 143,078 | $533.7K | 0.03% | +14,991+11.7% | Added |
| Jacobs Levy Equity Management, Inc | 121,559 | $453.4K | 0.00% | +121,559 | New |
| Two Sigma Investments, LP | 119,312 | $445.0K | 0.00% | −14,632−10.9% | Reduced |
| Tang Capital Management LLC | 118,857 | $443.3K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 105,846 | $394.9K | 0.00% | −2,158−2.0% | Reduced |
| Invesco Ltd. | 82,775 | $308.8K | 0.00% | +351+0.4% | Added |
| DGS Capital Management, LLC | 71,728 | $267.5K | 0.07% | +22,239+44.9% | Added |
| Union Square Park Capital Management, LLC | 56,963 | $212.5K | 0.29% | +56,963 | New |
| AJOVista, LLC | 56,438 | $210.5K | 0.90% | +45,206+402.5% | Added |
| D. E. Shaw & Co., Inc. | 54,625 | $203.8K | 0.00% | −116,383−68.1% | Reduced |
| Bank of America Corp | 51,006 | $190.3K | 0.00% | −274,513−84.3% | Reduced |
| Deutsche Bank AG | 48,800 | $182.0K | 0.00% | 00.0% | Unchanged |
| Trexquant Investment LP | 43,723 | $163.1K | 0.00% | −9,230−17.4% | Reduced |
| Royal Bank of Canada | 36,925 | $138.0K | 0.00% | −676−1.8% | Reduced |
| State Street Corp | 35,820 | $133.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 31,955 | $119.2K | 0.00% | −62,107−66.0% | Reduced |
| Bridgeway Capital Management, LLC | 31,900 | $119.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 31,495 | $117.5K | 0.00% | −47,598−60.2% | Reduced |
| PDT Partners, LLC | 30,011 | $111.9K | 0.01% | 00.0% | Unchanged |
| FMR LLC | 28,348 | $105.7K | 0.00% | −815−2.8% | Reduced |
| Citadel Advisors LLC | 26,013 | $97.0K | 0.00% | +26,013 | New |
| Jane Street Group, LLC | 25,837 | $96.4K | 0.00% | +25,837 | New |
| XTX Topco Ltd | 22,437 | $83.7K | 0.01% | +2,233+11.1% | Added |
| BNP Paribas Arbitrage, SA | 17,976 | $67.0K | 0.00% | −6,426−26.3% | Reduced |
| Creative Planning | 15,686 | $58.5K | 0.00% | +15,686 | New |
| JustInvest LLC | 15,530 | $57.9K | 0.00% | +1,901+13.9% | Added |
| Barclays PLC | 15,043 | $56.1K | 0.00% | −4,066−21.3% | Reduced |
| Royce & Associates LP | 13,821 | $51.6K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 13,300 | $50.0K | 0.00% | 00.0% | Unchanged |
| Blair William & Co | 12,952 | $48.3K | 0.00% | −148−1.1% | Reduced |
| Virtu Financial LLC | 12,890 | $48.0K | 0.00% | +12,890 | New |
| HSBC Holdings PLC | 11,396 | $45.0K | 0.00% | −1,752−13.3% | Reduced |
| Stanley-Laman Group, Ltd. | 12,000 | $44.8K | 0.01% | 00.0% | Unchanged |
| Jump Financial, LLC | 10,734 | $40.0K | 0.00% | −1,456−11.9% | Reduced |
| Simplex Trading, LLC | 8,355 | $31.0K | 0.00% | +8,355 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 7,773 | $29.0K | 0.01% | −3,839−33.1% | Reduced |
| Acadian Asset Management LLC | 7,155 | $26.0K | 0.00% | −19,235−72.9% | Reduced |
| Cubist Systematic Strategies, LLC | 6,152 | $22.9K | 0.00% | −19,660−76.2% | Reduced |
| WealthCollab, LLC | 5,617 | $21.0K | 0.01% | +1,242+28.4% | Added |
| Russell Investments Group, Ltd. | 3,561 | $13.3K | 0.00% | −6,237−63.7% | Reduced |
| Tower Research Capital LLC (TRC) | 2,702 | $10.1K | 0.00% | −494−15.5% | Reduced |
| HighMark Wealth Management LLC | 2,200 | $8.21K | 0.00% | +2,200 | New |
| Headlands Technologies LLC | 1,674 | $6.24K | 0.00% | +1,674 | New |
| Group One Trading, L.P. | 785 | $2.93K | 0.00% | +785 | New |
| UBS Group AG | 480 | $1.79K | 0.00% | −2−0.4% | Reduced |
| Archer Investment Corp | 350 | $1.31K | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 149 | $1.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 105 | $391 | 0.00% | −614−85.4% | Reduced |
| Farther Finance Advisors, LLC | 64 | $239 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 49 | $183 | 0.00% | 00.0% | Unchanged |
| Front Row Advisors LLC | 40 | $149 | 0.00% | 00.0% | Unchanged |
| Credit Agricole S A | 36 | $134 | 0.00% | +36 | New |
| The PNC Financial Services Group, Inc. | 28 | $104 | 0.00% | 00.0% | Unchanged |
| LSV Asset Management | 0 | $0 | 0.00% | −295,388−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −173,365−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −167,782−100.0% | Sold out |
| Los Angeles Capital Management LLC | 0 | $0 | 0.00% | −132,606−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −50,589−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −24,696−100.0% | Sold out |
| Great Lakes Advisors, LLC | 0 | $0 | 0.00% | −23,622−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −17,825−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −16,763−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −10,786−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −10,076−100.0% | Sold out |
| Fidelis Capital Partners, LLC | 0 | $0 | 0.00% | −12,762−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −8,118−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −7,246−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −4,881−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2,317−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −1,672−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −518−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −351−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |